首页> 美国卫生研究院文献>Acta Pharmaceutica Sinica. B >GSH-responsive SN38 dimer-loaded shape-transformable nanoparticles with iRGD for enhancing chemo-photodynamic therapy
【2h】

GSH-responsive SN38 dimer-loaded shape-transformable nanoparticles with iRGD for enhancing chemo-photodynamic therapy

机译:GSH响应SN38二聚体加载的形状可变性纳米颗粒具有IRGD用于增强化学光动力疗法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Accurate tumor targeting, deep penetration and superb retention are still the main pursuit of developing excellent nanomedicine. To achieve these requirements, a stepwise stimuli-responsive strategy was developed through co-administration tumor penetration peptide iRGD with shape-transformable and GSH-responsive SN38-dimer (d-SN38)-loaded nanoparticles (d-SN38@NPs/iRGD). Upon intravenous injection, d-SN38@NPs with high drug loading efficiency (33.92 ± 1.33%) could effectively accumulate and penetrate into the deep region of tumor sites with the assistance of iRGD. The gathered nanoparticles simultaneously transformed into nanofibers upon 650 nm laser irradiation at tumor sites so as to promote their retention in the tumor and burst release of reactive oxygen species for photodynamic therapy. The loaded d-SN38 with disulfide bond responded to the high level of GSH in tumor cytoplasm, which consequently resulted in SN38 release and excellent chemo-photodynamic effect on tumor. In vitro, co-administering iRGD with d-SN38@NPs+laser showed higher cellular uptake, apoptosis ratio and multicellular spheroid penetration. In vivo, d-SN38@NPs/iRGD+laser displayed advanced penetration and accumulation in tumor, leading to 60.89% of tumor suppression in 4T1 tumor-bearing mouse model with a favorable toxicity profile. Our new strategy combining iRGD with structural transformable nanoparticles greatly improves tumor targeting, penetrating and retention, and empowers anticancer efficacy.
机译:准确的肿瘤靶向,深渗透和精湛的保留仍然是开发优质纳米胺的主要追求。为了达到这些要求,通过共同给予肿瘤渗透肽IRGD和GSH响应SN38二聚体(D-SN38) - 加载的纳米颗粒(D-SN38 @ NPS / IRGD),通过共同施用肿瘤渗透肽IRGD来开发逐步刺激响应策略。在静脉注射时,具有高药物负载效率的D-SN38 @ NPS(33.92±1.33%)可以有效地积累并渗透到IRGD的肿瘤部位深处。将聚集的纳米颗粒同时转化为肿瘤位点的650nm激光照射时在纳米纤维中转化为纳米纤维,以促进它们在肿瘤中的保留和反应性释放用于光动力疗法的活性氧。具有二硫键的加载的D-Sn38响应肿瘤细胞质中的高水平GSH,其导致SN38释放和优异的肿瘤的化学光动力学作用。体外,用D-SN38 @ NPS +激光共同施用IRGD,显示出更高的细胞吸收,凋亡率和多细胞球体渗透。在体内,D-SN38 @ NPS / IRGD +激光显示出肿瘤的高级渗透和积聚,导致4T1肿瘤小鼠模型中肿瘤抑制的60.89%,具有良好的毒性曲线。我们的新策略与结构可转化的纳米粒子相结合的IRGD大大改善了肿瘤靶向,渗透和保留,并且赋予抗癌功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号